Moderna, Inc. Common Stock

Go to Moderna, Inc. Common Stock Website

$27.72

-1.84 (-6.22%)
Live
Previous Close

$27.605

Day Range

$26.5648 - $27.88

Previous Day Range

$29.31 - $31.845

Market Cap

$10.7 billion USD

Day Vol.

16.3 million

Previous Day Vol.

14.5 million

Currency

USD

Primary Exchange

Nasdaq

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. ...


Community
  • 0 posts discussing
0

Watchers

1

Visitors


Recent News

Moderna reported Q2 earnings with a loss of $2.13 per share, beating estimates but experiencing a 41% revenue drop due to falling COVID-19 vaccine sales. The company received a key patent win against Pfizer/BioNTech but lowered its 2025 revenue outlook.

Related tickers: MRNA, PFE, BNTX.

Read Full Article

Alnylam Pharmaceuticals reported strong Q2 earnings, with sales rising 17% to $773.69 million, exceeding analyst estimates. The company raised its 2025 revenue guidance by 27% and showed significant growth in its TTR and Rare disease product revenues.

Related tickers: ALNY, MRNA.

Read Full Article
Trending Tickers

Please sign in to view